Found 5 matching trials
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
PHASE3The main aim of the study is to evaluate the effectiveness of prophylaxis w...
Location
University of Alabama at Birmingham
Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)
N/AThe post-trial access program allows eligible participants to gain access t...
Location
Multiple Locations
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
PHASE3The main aim of the study is to check effectiveness, side effects, and tole...
Location
University of Colorado Hemophilia & Thrombosis Center
An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)
N/AThis study is conducted in Japan of vonicog alfa (rVWF) used to treat pedia...
Location
Takeda selected site
A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
PHASE3The main aim of this study is to find out if VONVENDI is safe for adult Chi...
Location
Peking Union Medical College Hospital